Myriad Genetics (MYGN) Current Deferred Tax Assets (2010 - 2015)

Myriad Genetics (MYGN) has 6 years of Current Deferred Tax Assets data on file, last reported at $13.5 million in Q3 2015.

• Current Deferred Tax Assets for Q3 2015 came in at $13.5 million, up 2.05% year-over-year; the trailing twelve-month figure through Sep 2015 was $13.5 million (up 2.05% YoY), and the FY2015 annual result was $13.5 million, up 107.69% from the prior year.
• Current Deferred Tax Assets was little changed at $13.5 million in Q3 2015 per MYGN's latest filing, from $13.5 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $13.5 million in Q2 2015 and troughed at $4.4 million in Q1 2011.
• A 5-year average of $9.2 million and a median of $8.8 million in 2013 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2011 and 2015: Current Deferred Tax Assets sank 47.25% in 2011, then surged 107.69% in 2015.
• A 5-year view of Current Deferred Tax Assets shows it stood at $7.8 million in 2011, then climbed by 20.14% to $9.4 million in 2012, then decreased by 2.99% to $9.1 million in 2013, then soared by 41.21% to $12.8 million in 2014, then increased by 5.36% to $13.5 million in 2015.
• Business Quant data shows MYGN's Current Deferred Tax Assets at $13.5 million in Q3 2015, $13.5 million in Q2 2015, and $13.5 million in Q1 2015.